Skip to content
AwardedDNKGoodsFramework agreementDKK 1

Rammeaftale om køb af Beyfortus (nirsevimab)

Published
Published 11 December 2024

Overview

Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Beyfortus (nirsevimab). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.

Key details

Country
DNK
Status
Awarded
Category
Goods
Estimated value
DKK 1
Procedure
Direct
Contract type
Framework agreement
Published
11 December 2024
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
DKK 1
Award date
13 October 2025
Contract period
13 October 2025 → 30 June 2026
Winner
  • Sanofi A/S

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 March 2026

  2. Contract Notice

    11 December 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Rammeaftale om køb af Beyfortus (nirsevimab) — won by Sanofi A/S — Skim